Skip to main content
Subscribe
Log In
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
Basket
Search
More
Search for this keyword
Advanced search
Latest content
Current issue
Archive
JNNP 100
Authors
Podcasts
About
Search for this keyword
Advanced search
Close
More
Main menu
Latest content
Current issue
Archive
JNNP 100
Authors
Podcasts
About
Subscribe
Log in
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
BMJ Journals
More
You are here
Home
Archive
Volume 92, Issue 3
Systematic approach to selecting licensed drugs for repurposing in the treatment of progressive multiple sclerosis
Email alerts
Article metrics
Article menu
Article
Text
Article
info
Citation
Tools
Share
Responses
Article
metrics
Alerts
PDF
Multiple sclerosis
Original research
Systematic approach to selecting licensed drugs for repurposing in the treatment of progressive multiple sclerosis
Free
Online download statistics by month:
Online download statistics by month: November 2020 to April 2021
Abstract
Full
Pdf
Nov 2020
2580
114
69
Dec 2020
1049
30
15
Jan 2021
469
30
11
Feb 2021
589
432
96
Mar 2021
525
511
188
Apr 2021
240
227
125
Total
5452
1344
504
Read the full text or download the PDF:
Subscribe
Log in
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
PDF